This earnings news release for Manulife Financial Corporation (“Manulife” or the “Company”) should be read in
conjunction with the Company’s Second Quarter 2022 Report to Shareholders, including our unaudited interim Consolidated Financial Statements for the three and six months ended June 30, 2022, prepared in accordance with International
Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”), which are available on our website at www.manulife.com/en/investors/results-and-reports. The MD&A and additional information relating to the Company is available on the SEDAR website at http://www.sedar.com and on the U.S. Securities and Exchange Commission's (“SEC”) website at http://www.sec.gov.
|
◾ |
Net income attributed to shareholders of $1.1 billion in 2Q22, down $1.6 billion from the second quarter of 2021 (“2Q21”)
|
◾ |
Core earnings1 of $1.6 billion in 2Q22, down 9% on a constant exchange rate basis from 2Q212
|
◾ |
LICAT ratio3 of 137%
|
◾ |
Core ROE4 of 12.1% and ROE of 8.3% in 2Q22
|
◾ |
NBV5 of $511 million in 2Q22, down 9%5 from 2Q21
|
◾ |
APE sales5 of $1.4 billion in 2Q22, down 1% from 2Q21
|
◾ |
Global Wealth and Asset Management (“Global WAM”) net inflows5 of $1.7 billion in 2Q22, compared with net inflows of $8.6 billion in 2Q21
|
◾ |
Expense efficiency ratio4 of 49.2%, compared with our target of less than 50%, and general expenses decreased 3%6
|
1 |
Core earnings is a non-GAAP financial measure. For more information on non-GAAP and other financial measures, see “Non-GAAP and other financial measures” below and in our Second
Quarter 2022 Management’s Discussion and Analysis (“2Q22 MD&A”) for additional information.
|
2 |
Percentage growth / declines in core earnings stated on a constant exchange rate basis is a non-GAAP ratio.
|
3 |
Life Insurance Capital Adequacy Test (“LICAT”) ratio of The Manufacturers Life Insurance Company (“MLI”). LICAT ratio is disclosed under the Office of the Superintendent of Financial
Institutions Canada’s (“OSFI’s”) Life Insurance Capital Adequacy Test Public Disclosure Requirements guideline.
|
4 |
Core return on common shareholders’ equity (“Core ROE”) and expense efficiency ratio are non-GAAP ratios.
|
5 |
For more information on new business value (“NBV”), annualized premium equivalent (“APE”) sales and net flows, see “Non-GAAP and other financial measures” below. In this news
release, percentage growth / declines in NBV and APE sales are stated on a constant exchange rate basis.
|
6 |
General expenses percentage decline stated on an actual exchange rate basis.
|
7 |
Canada segment is comprised of the Insurance, Annuities, and Manulife Bank businesses. U.S. segment is comprised of the U.S. Insurance and U.S. Annuities businesses.
|
1 |
Recognized a one-time after-tax gain of $842 million in the first quarter of 2022 (“1Q22”).
|
2 |
Excludes $63 million (pre-tax) of lost expected profit on in-force relating to the U.S. variable annuity reinsurance transaction that closed in 1Q22.
|
3 |
As of August 8, 2022, the Company has purchased for cancellation approximately 38 million common shares for $933 million.
|
Quarterly Results
|
YTD Results
|
|||||||||||||||
($ millions, unless otherwise stated)
|
2Q22
|
2Q21
|
2022
|
2021
|
||||||||||||
Profitability:
|
||||||||||||||||
Net income attributed to shareholders
|
$
|
1,086
|
$
|
2,646
|
$
|
4,056
|
$
|
3,429
|
||||||||
Core earnings
|
$
|
1,562
|
$
|
1,682
|
$
|
3,114
|
$
|
3,311
|
||||||||
Diluted earnings per common share ($)
|
$
|
0.53
|
$
|
1.33
|
$
|
2.04
|
$
|
1.71
|
||||||||
Diluted core earnings per common share (“Core EPS”) ($)(1)
|
$
|
0.78
|
$
|
0.83
|
$
|
1.55
|
$
|
1.65
|
||||||||
Return on common shareholders’ equity (“ROE”)
|
8.3
|
%
|
22.2
|
%
|
15.7
|
%
|
14.3
|
%
|
||||||||
Core ROE
|
12.1
|
%
|
13.9
|
%
|
12.0
|
%
|
13.8
|
%
|
||||||||
Expense efficiency ratio
|
49.2
|
%
|
46.8
|
%
|
49.6
|
%
|
47.7
|
%
|
||||||||
General expenses
|
$
|
1,843
|
$
|
1,892
|
$
|
3,741
|
$
|
3,924
|
||||||||
Business Performance:
|
||||||||||||||||
Asia new business value
|
$
|
337
|
$
|
399
|
$
|
677
|
$
|
876
|
||||||||
Canada new business value
|
$
|
82
|
$
|
76
|
$
|
186
|
$
|
154
|
||||||||
U.S. new business value
|
$
|
92
|
$
|
75
|
$
|
161
|
$
|
119
|
||||||||
Total new business value
|
$
|
511
|
$
|
550
|
$
|
1,024
|
$
|
1,149
|
||||||||
Asia APE sales
|
$
|
838
|
$
|
950
|
$
|
1,886
|
$
|
2,230
|
||||||||
Canada APE sales
|
$
|
361
|
$
|
274
|
$
|
724
|
$
|
629
|
||||||||
U.S. APE sales
|
$
|
209
|
$
|
191
|
$
|
408
|
$
|
341
|
||||||||
Total APE sales
|
$
|
1,408
|
$
|
1,415
|
$
|
3,018
|
$
|
3,200
|
||||||||
Global WAM net flows ($ billions)
|
$
|
1.7
|
$
|
8.6
|
$
|
8.6
|
$
|
10.0
|
||||||||
Global WAM gross flows ($ billions)(2)
|
$
|
33.6
|
$
|
33.7
|
$
|
72.1
|
$
|
73.4
|
||||||||
Global WAM assets under management and administration ($ billions)(3)
|
$
|
744.7
|
$
|
798.5
|
$
|
744.7
|
$
|
798.5
|
||||||||
Global WAM total invested assets ($ billions)
|
$
|
4.0
|
$
|
4.2
|
$
|
4.0
|
$
|
4.2
|
||||||||
Global WAM net segregated funds net assets ($ billions)
|
$
|
213.3
|
$
|
242.6
|
$
|
213.3
|
$
|
242.6
|
||||||||
Financial Strength:
|
||||||||||||||||
MLI’s LICAT ratio
|
137
|
%
|
137
|
%
|
137
|
%
|
137
|
%
|
||||||||
Financial leverage ratio
|
28.5
|
%
|
25.9
|
%
|
28.5
|
%
|
25.9
|
%
|
||||||||
Book value per common share ($)
|
$
|
25.56
|
$
|
24.76
|
$
|
25.56
|
$
|
24.76
|
||||||||
Book value per common share excluding AOCI ($)
|
$
|
25.49
|
$
|
22.89
|
$
|
25.49
|
$
|
22.89
|
(1) |
This item is a non-GAAP ratio.
|
(2) |
For more information on gross flows, see “Non-GAAP and other financial measures” below.
|
(3) |
This item is a non-GAAP financial measure.
|
1 |
See “Caution regarding forward-looking statements” below.
|
2 |
Asia Other excludes Hong Kong and Japan.
|
Media Inquiries
Cheryl Holmes
(416) 557-0945
Cheryl_Holmes@manulife.com
|
Investor Relations
Hung Ko
(416) 806-9921
Hung_Ko@manulife.com
|
Quarterly Results
|
YTD Results
|
|||||||||||||||||||
($ millions)
|
2Q22
|
1Q22
|
2Q21
|
2022
|
2021
|
|||||||||||||||
Core earnings
|
||||||||||||||||||||
Asia
|
$
|
513
|
$
|
537
|
$
|
526
|
$
|
1,050
|
$
|
1,096
|
||||||||||
Canada
|
345
|
314
|
318
|
659
|
582
|
|||||||||||||||
U.S.
|
456
|
486
|
478
|
942
|
979
|
|||||||||||||||
Global Wealth and Asset Management
|
305
|
324
|
356
|
629
|
668
|
|||||||||||||||
Corporate and Other (excluding core investment gains)
|
(157
|
)
|
(209
|
)
|
(96
|
)
|
(366
|
)
|
(214
|
)
|
||||||||||
Core investment gains(1)
|
100
|
100
|
100
|
200
|
200
|
|||||||||||||||
Total core earnings
|
$
|
1,562
|
$
|
1,552
|
$
|
1,682
|
$
|
3,114
|
$
|
3,311
|
||||||||||
Items excluded from core earnings:(1)
Investment-related experience outside of core earnings
|
591
|
558
|
739
|
1,149
|
816
|
|||||||||||||||
Direct impact of equity markets and interest rates and variable annuity guarantee
liabilities
|
(1,067
|
)
|
97
|
217
|
(970
|
)
|
(618
|
)
|
||||||||||||
Restructuring charge
|
-
|
-
|
-
|
-
|
(115
|
)
|
||||||||||||||
Reinsurance transaction, tax-related items and other
|
-
|
763
|
8
|
763
|
35
|
|||||||||||||||
Net income attributed to shareholders
|
$
|
1,086
|
$
|
2,970
|
$
|
2,646
|
$
|
4,056
|
$
|
3,429
|
(1) |
These items are disclosed under OSFI’s Source of Earnings Disclosure (Life Insurance Companies) guideline.
|
2Q22 | ||||||||||||||||||||||||
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
|
Asia
|
Canada
|
U.S.
|
Global
WAM
|
Corporate
and Other
|
Total
|
||||||||||||||||||
Income (loss) before income taxes
|
$
|
216
|
$
|
224
|
$
|
1,010
|
$
|
362
|
$
|
(555
|
)
|
$
|
1,257
|
|||||||||||
Income tax (expense) recovery
|
||||||||||||||||||||||||
Core earnings
|
(74
|
)
|
(119
|
)
|
(92
|
)
|
(57
|
)
|
4
|
(338
|
)
|
|||||||||||||
Items excluded from core earnings
|
44
|
64
|
(82
|
)
|
-
|
54
|
80
|
|||||||||||||||||
Income tax (expense) recovery
|
(30
|
)
|
(55
|
)
|
(174
|
)
|
(57
|
)
|
58
|
(258
|
)
|
|||||||||||||
Net income (post-tax)
|
186
|
169
|
836
|
305
|
(497
|
)
|
999
|
|||||||||||||||||
Less: Net income (post-tax) attributed to
|
||||||||||||||||||||||||
Non-controlling interests
|
(11
|
)
|
-
|
-
|
-
|
-
|
(11
|
)
|
||||||||||||||||
Participating policyholders
|
(164
|
)
|
84
|
4
|
-
|
-
|
(76
|
)
|
||||||||||||||||
Net income (loss) attributed to shareholders
(post-tax)
|
361
|
85
|
832
|
305
|
(497
|
)
|
1,086
|
|||||||||||||||||
Less: Items excluded from core earnings(1)
|
||||||||||||||||||||||||
Investment-related experience outside of core earnings
|
80
|
86
|
591
|
-
|
(166
|
)
|
591
|
|||||||||||||||||
Direct impact of equity markets and interest rates and variable annuity guarantee liabilities
|
(232
|
)
|
(346
|
)
|
(215
|
)
|
-
|
(274
|
)
|
(1,067
|
)
|
|||||||||||||
Change in actuarial methods and assumptions
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||
Restructuring charge
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||
Reinsurance transactions, tax related items and
other
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||
Core earnings (post-tax)
|
$
|
513
|
$
|
345
|
$
|
456
|
$
|
305
|
$
|
(57
|
)
|
$
|
1,562
|
|||||||||||
Income tax on core earnings (see above)
|
74
|
119
|
92
|
57
|
(4
|
)
|
338
|
|||||||||||||||||
Core earnings (pre-tax)
|
$
|
587
|
$
|
464
|
$
|
548
|
$
|
362
|
$
|
(61
|
)
|
$
|
1,900
|
(1) |
These items are disclosed under OSFI’s Source of Earnings Disclosure (Life Insurance Companies) guideline.
|
2Q22 | ||||||||||||||||||||||||
(Canadian $ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
|
Asia
|
Canada
|
U.S.
|
Global
WAM
|
Corporate
and Other
|
Total
|
||||||||||||||||||
Core earnings (post-tax)
|
$
|
513
|
$
|
345
|
$
|
456
|
$
|
305
|
$
|
(57
|
)
|
$
|
1,562
|
|||||||||||
CER adjustment(1)
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||
Core earnings, CER basis (post-tax)
|
$
|
513
|
$
|
345
|
$
|
456
|
$
|
305
|
$
|
(57
|
)
|
$
|
1,562
|
|||||||||||
Income tax on core earnings, CER basis(2)
|
74
|
119
|
92
|
57
|
(4
|
)
|
338
|
|||||||||||||||||
Core earnings, CER basis (pre-tax)
|
$
|
587
|
$
|
464
|
$
|
548
|
$
|
362
|
$
|
(61
|
)
|
$
|
1,900
|
(1) |
The impact of updating foreign exchange rates to that which was used in 2Q22.
|
(2) |
Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q22.
|
1Q22 | ||||||||||||||||||||||||
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
|
Asia
|
Canada
|
U.S.
|
Global
WAM
|
Corporate
and Other
|
Total
|
||||||||||||||||||
Income (loss) before income taxes
|
$
|
681
|
$
|
880
|
$
|
2,577
|
$
|
386
|
$
|
(813
|
)
|
$
|
3,711
|
|||||||||||
Income tax (expense) recovery
|
||||||||||||||||||||||||
Core earnings
|
(74
|
)
|
(110
|
)
|
(105
|
)
|
(61
|
)
|
26
|
(324
|
)
|
|||||||||||||
Items excluded from core earnings
|
(11
|
)
|
(115
|
)
|
(405
|
)
|
-
|
46
|
(485
|
)
|
||||||||||||||
Income tax (expense) recovery
|
(85
|
)
|
(225
|
)
|
(510
|
)
|
(61
|
)
|
72
|
(809
|
)
|
|||||||||||||
Net income (post-tax)
|
596
|
655
|
2,067
|
325
|
(741
|
)
|
2,902
|
|||||||||||||||||
Less: Net income (post-tax) attributed to
|
||||||||||||||||||||||||
Non-controlling interests
|
20
|
-
|
-
|
1
|
-
|
21
|
||||||||||||||||||
Participating policyholders
|
(197
|
)
|
108
|
-
|
-
|
-
|
(89
|
)
|
||||||||||||||||
Net income (loss) attributed to shareholders
(post-tax)
|
773
|
547
|
2,067
|
324
|
(741
|
)
|
2,970
|
|||||||||||||||||
Less: Items excluded from core earnings(1)
|
||||||||||||||||||||||||
Investment-related experience outside of core earnings
|
64
|
53
|
527
|
-
|
(86
|
)
|
558
|
|||||||||||||||||
Direct impact of equity markets and interest rates and variable annuity guarantee liabilities
|
180
|
180
|
212
|
-
|
(475
|
)
|
97
|
|||||||||||||||||
Change in actuarial methods and assumptions
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||
Restructuring charge
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||
Reinsurance transactions, tax related items and
other
|
(8
|
)
|
-
|
842
|
-
|
(71
|
)
|
763
|
||||||||||||||||
Core earnings (post-tax)
|
$
|
537
|
$
|
314
|
$
|
486
|
$
|
324
|
$
|
(109
|
)
|
$
|
1,552
|
|||||||||||
Income tax on core earnings (see above)
|
74
|
110
|
105
|
61
|
(26
|
)
|
324
|
|||||||||||||||||
Core earnings (pre-tax)
|
$
|
611
|
$
|
424
|
$
|
591
|
$
|
385
|
$
|
(135
|
)
|
$
|
1,876
|
(1) |
These items are disclosed under OSFI’s Source of Earnings Disclosure (Life Insurance Companies) guideline.
|
1Q22 | ||||||||||||||||||||||||
(Canadian $ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
|
Asia
|
Canada
|
U.S.
|
Global
WAM
|
Corporate
and Other
|
Total
|
||||||||||||||||||
Core earnings (post-tax)
|
$
|
537
|
$
|
314
|
$
|
486
|
$
|
324
|
$
|
(109
|
)
|
$
|
1,552
|
|||||||||||
CER adjustment(1)
|
(10
|
)
|
-
|
4
|
1
|
-
|
(5
|
)
|
||||||||||||||||
Core earnings, CER basis (post-tax)
|
$
|
527
|
$
|
314
|
$
|
490
|
$
|
325
|
$
|
(109
|
)
|
$
|
1,547
|
|||||||||||
Income tax on core earnings, CER basis(2)
|
72
|
110
|
106
|
61
|
(26
|
)
|
323
|
|||||||||||||||||
Core earnings, CER basis (pre-tax)
|
$
|
599
|
$
|
424
|
$
|
596
|
$
|
386
|
$
|
(135
|
)
|
$
|
1,870
|
(1) |
The impact of updating foreign exchange rates to that which was used in 2Q22.
|
(2) |
Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q22.
|
2Q21 | ||||||||||||||||||||||||
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
|
Asia
|
Canada
|
U.S.
|
Global
WAM
|
Corporate
and Other
|
Total
|
||||||||||||||||||
Income (loss) before income taxes
|
$
|
736
|
$
|
1,031
|
$
|
986
|
$
|
419
|
$
|
120
|
$
|
3,292
|
||||||||||||
Income tax (expense) recovery
|
||||||||||||||||||||||||
Core earnings
|
(78
|
)
|
(112
|
)
|
(106
|
)
|
(64
|
)
|
6
|
(354
|
)
|
|||||||||||||
Items excluded from core earnings
|
(22
|
)
|
(107
|
)
|
(83
|
)
|
1
|
(45
|
)
|
(256
|
)
|
|||||||||||||
Income tax (expense) recovery
|
(100
|
)
|
(219
|
)
|
(189
|
)
|
(63
|
)
|
(39
|
)
|
(610
|
)
|
||||||||||||
Net income (post-tax)
|
636
|
812
|
797
|
356
|
81
|
2,682
|
||||||||||||||||||
Less: Net income (post-tax) attributed to
|
||||||||||||||||||||||||
Non-controlling interests
|
84
|
-
|
-
|
-
|
-
|
84
|
||||||||||||||||||
Participating policyholders
|
(81
|
)
|
29
|
4
|
-
|
-
|
(48
|
)
|
||||||||||||||||
Net income (loss) attributed to shareholders
(post-tax)
|
633
|
783
|
793
|
356
|
81
|
2,646
|
||||||||||||||||||
Less: Items excluded from core earnings(1)
|
||||||||||||||||||||||||
Investment-related experience outside of core earnings
|
121
|
207
|
506
|
-
|
(95
|
)
|
739
|
|||||||||||||||||
Direct impact of equity markets and interest rates and variable annuity guarantee liabilities
|
(22
|
)
|
258
|
(191
|
)
|
-
|
172
|
217
|
||||||||||||||||
Change in actuarial methods and assumptions
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||
Restructuring charge
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||
Reinsurance transactions, tax related items and
other
|
8
|
-
|
-
|
-
|
-
|
8
|
||||||||||||||||||
Core earnings (post-tax)
|
$
|
526
|
$
|
318
|
$
|
478
|
$
|
356
|
$
|
4
|
$
|
1,682
|
||||||||||||
Income tax on core earnings (see above)
|
78
|
112
|
106
|
64
|
(6
|
)
|
354
|
|||||||||||||||||
Core earnings (pre-tax)
|
$
|
604
|
$
|
430
|
$
|
584
|
$
|
420
|
$
|
(2
|
)
|
$
|
2,036
|
(1) |
These items are disclosed under OSFI’s Source of Earnings Disclosure (Life Insurance Companies) guideline.
|
2Q21 | ||||||||||||||||||||||||
(Canadian $ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
|
Asia
|
Canada
|
U.S.
|
Global
WAM
|
Corporate
and Other
|
Total
|
||||||||||||||||||
Core earnings (post-tax)
|
$
|
526
|
$
|
318
|
$
|
478
|
$
|
356
|
$
|
4
|
$
|
1,682
|
||||||||||||
CER adjustment(1)
|
1
|
-
|
19
|
9
|
1
|
30
|
||||||||||||||||||
Core earnings, CER basis (post-tax)
|
$
|
527
|
$
|
318
|
$
|
497
|
$
|
365
|
$
|
5
|
$
|
1,712
|
||||||||||||
Income tax on core earnings, CER basis(2)
|
80
|
111
|
109
|
65
|
(5
|
)
|
360
|
|||||||||||||||||
Core earnings, CER basis (pre-tax)
|
$
|
607
|
$
|
429
|
$
|
606
|
$
|
430
|
$
|
-
|
$
|
2,072
|
(1) |
The impact of updating foreign exchange rates to that which was used in 2Q22.
|
(2) |
Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q22.
|
YTD 2022
|
||||||||||||||||||||||||
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
|
Asia
|
Canada
|
U.S.
|
Global
WAM
|
Corporate
and Other
|
Total
|
||||||||||||||||||
Income (loss) before income taxes
|
$
|
897
|
$
|
1,104
|
$
|
3,587
|
$
|
748
|
$
|
(1,368
|
)
|
$
|
4,968
|
|||||||||||
Income tax (expense) recovery
|
||||||||||||||||||||||||
Core earnings
|
(148
|
)
|
(229
|
)
|
(197
|
)
|
(118
|
)
|
30
|
(662
|
)
|
|||||||||||||
Items excluded from core earnings
|
33
|
(51
|
)
|
(487
|
)
|
-
|
100
|
(405
|
)
|
|||||||||||||||
Income tax (expense) recovery
|
(115
|
)
|
(280
|
)
|
(684
|
)
|
(118
|
)
|
130
|
(1,067
|
)
|
|||||||||||||
Net income (post-tax)
|
782
|
824
|
2,903
|
630
|
(1,238
|
)
|
3,901
|
|||||||||||||||||
Less: Net income (post-tax) attributed to
|
||||||||||||||||||||||||
Non-controlling interests
|
9
|
-
|
-
|
1
|
-
|
10
|
||||||||||||||||||
Participating policyholders
|
(361
|
)
|
192
|
4
|
-
|
-
|
(165
|
)
|
||||||||||||||||
Net income (loss) attributed to shareholders
(post-tax)
|
1,134
|
632
|
2,899
|
629
|
(1,238
|
)
|
4,056
|
|||||||||||||||||
Less: Items excluded from core earnings(1)
|
||||||||||||||||||||||||
Investment-related experience outside of core earnings
|
144
|
139
|
1,118
|
-
|
(252
|
)
|
1,149
|
|||||||||||||||||
Direct impact of equity markets and interest rates and variable annuity guarantee liabilities
|
(52
|
)
|
(166
|
)
|
(3
|
)
|
-
|
(749
|
)
|
(970
|
)
|
|||||||||||||
Change in actuarial methods and assumptions
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||
Restructuring charge
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||
Reinsurance transactions, tax related items and
other
|
(8
|
)
|
-
|
842
|
-
|
(71
|
)
|
763
|
||||||||||||||||
Core earnings (post-tax)
|
$
|
1,050
|
$
|
659
|
$
|
942
|
$
|
629
|
$
|
(166
|
)
|
$
|
3,114
|
|||||||||||
Income tax on core earnings (see above)
|
148
|
229
|
197
|
118
|
(30
|
)
|
662
|
|||||||||||||||||
Core earnings (pre-tax)
|
$
|
1,198
|
$
|
888
|
$
|
1,139
|
$
|
747
|
$
|
(196
|
)
|
$
|
3,776
|
(1) |
These items are disclosed under OSFI’s Source of Earnings Disclosure (Life Insurance Companies) guideline.
|
YTD 2022
|
||||||||||||||||||||||||
(Canadian $ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
|
Asia
|
Canada
|
U.S.
|
Global
WAM
|
Corporate
and Other
|
Total
|
||||||||||||||||||
Core earnings (post-tax)
|
$
|
1,050
|
$
|
659
|
$
|
942
|
$
|
629
|
$
|
(166
|
)
|
$
|
3,114
|
|||||||||||
CER adjustment(1)
|
(10
|
)
|
-
|
4
|
1
|
-
|
(5
|
)
|
||||||||||||||||
Core earnings, CER basis (post-tax)
|
$
|
1,040
|
$
|
659
|
$
|
946
|
$
|
630
|
$
|
(166
|
)
|
$
|
3,109
|
|||||||||||
Income tax on core earnings, CER basis(2)
|
146
|
229
|
198
|
118
|
(30
|
)
|
661
|
|||||||||||||||||
Core earnings, CER basis (pre-tax)
|
$
|
1,186
|
$
|
888
|
$
|
1,144
|
$
|
748
|
$
|
(196
|
)
|
$
|
3,770
|
(1) |
The impact of updating foreign exchange rates to that which was used in 2Q22.
|
(2) |
Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q22.
|
YTD 2021
|
||||||||||||||||||||||||
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
|
Asia
|
Canada
|
U.S.
|
Global
WAM
|
Corporate
and Other
|
Total
|
||||||||||||||||||
Income (loss) before income taxes
|
$
|
1,854
|
$
|
1,086
|
$
|
1,070
|
$
|
785
|
$
|
(631
|
)
|
$
|
4,164
|
|||||||||||
Income tax (expense) recovery
|
||||||||||||||||||||||||
Core earnings
|
(202
|
)
|
(203
|
)
|
(222
|
)
|
(116
|
)
|
23
|
(720
|
)
|
|||||||||||||
Items excluded from core earnings
|
(76
|
)
|
1
|
52
|
-
|
126
|
103
|
|||||||||||||||||
Income tax (expense) recovery
|
(278
|
)
|
(202
|
)
|
(170
|
)
|
(116
|
)
|
149
|
(617
|
)
|
|||||||||||||
Net income (post-tax)
|
1,576
|
884
|
900
|
669
|
(482
|
)
|
3,547
|
|||||||||||||||||
Less: Net income (post-tax) attributed to
|
||||||||||||||||||||||||
Non-controlling interests
|
174
|
-
|
-
|
1
|
-
|
175
|
||||||||||||||||||
Participating policyholders
|
(188
|
)
|
120
|
11
|
-
|
-
|
(57
|
)
|
||||||||||||||||
Net income (loss) attributed to shareholders
(post-tax)
|
1,590
|
764
|
889
|
668
|
(482
|
)
|
3,429
|
|||||||||||||||||
Less: Items excluded from core earnings(1)
|
||||||||||||||||||||||||
Investment-related experience outside of core earnings
|
193
|
142
|
666
|
-
|
(185
|
)
|
816
|
|||||||||||||||||
Direct impact of equity markets and interest rates and variable annuity guarantee liabilities
|
266
|
40
|
(756
|
)
|
-
|
(168
|
)
|
(618
|
)
|
|||||||||||||||
Change in actuarial methods and assumptions
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||
Restructuring charge
|
-
|
-
|
-
|
-
|
(115
|
)
|
(115
|
)
|
||||||||||||||||
Reinsurance transactions, tax related items and
other
|
35
|
-
|
-
|
-
|
-
|
35
|
||||||||||||||||||
Core earnings (post-tax)
|
$
|
1,096
|
$
|
582
|
$
|
979
|
$
|
668
|
$
|
(14
|
)
|
$
|
3,311
|
|||||||||||
Income tax on core earnings (see above)
|
202
|
203
|
222
|
116
|
(23
|
)
|
720
|
|||||||||||||||||
Core earnings (pre-tax)
|
$
|
1,298
|
$
|
785
|
$
|
1,201
|
$
|
784
|
$
|
(37
|
)
|
$
|
4,031
|
(1) |
These items are disclosed under OSFI’s Source of Earnings Disclosure (Life Insurance Companies) guideline.
|
YTD 2021
|
||||||||||||||||||||||||
(Canadian $ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
|
Asia
|
Canada
|
U.S.
|
Global
WAM
|
Corporate
and Other
|
Total
|
||||||||||||||||||
Core earnings (post-tax)
|
$
|
1,096
|
$
|
582
|
$
|
979
|
$
|
668
|
$
|
(14
|
)
|
$
|
3,311
|
|||||||||||
CER adjustment(1)
|
(18
|
)
|
-
|
23
|
10
|
1
|
16
|
|||||||||||||||||
Core earnings, CER basis (post-tax)
|
$
|
1,078
|
$
|
582
|
$
|
1,002
|
$
|
678
|
$
|
(13
|
)
|
$
|
3,327
|
|||||||||||
Income tax on core earnings, CER basis(2)
|
200
|
202
|
227
|
117
|
(23
|
)
|
723
|
|||||||||||||||||
Core earnings, CER basis (pre-tax)
|
$
|
1,278
|
$
|
784
|
$
|
1,229
|
$
|
795
|
$
|
(36
|
)
|
$
|
4,050
|
(1) |
The impact of updating foreign exchange rates to that which was used in 2Q22.
|
(2) |
Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q22.
|
Quarterly Results
|
YTD Results
|
Full Year Results
|
||||||||||||||||||||||||||||||
2Q22
|
1Q22
|
4Q21
|
3Q21
|
2Q21
|
2022
|
2021
|
2021
|
|||||||||||||||||||||||||
Core earnings
|
$
|
1,562
|
$
|
1,552
|
$
|
1,708
|
$
|
1,517
|
$
|
1,682
|
$
|
3,114
|
$
|
3,311
|
$
|
6,536
|
||||||||||||||||
Less: Preferred share dividends
|
(60
|
)
|
(52
|
)
|
(71
|
)
|
(37
|
)
|
(64
|
)
|
(112
|
)
|
(107
|
)
|
(215
|
)
|
||||||||||||||||
Core earnings available to common shareholders
|
1,502
|
1,500
|
1,637
|
1,480
|
1,618
|
3,002
|
3,204
|
6,321
|
||||||||||||||||||||||||
CER adjustment(1)
|
-
|
(5
|
)
|
2
|
(5
|
)
|
30
|
(5
|
)
|
16
|
13
|
|||||||||||||||||||||
Core earnings available to common shareholders, CER basis
|
$
|
1,502
|
$
|
1,495
|
$
|
1,639
|
$
|
1,475
|
$
|
1,648
|
$
|
2,997
|
$
|
3,220
|
$
|
6,334
|
(1) |
The impact of updating foreign exchange rates to that which was used in 2Q22.
|
Quarterly Results
|
YTD Results
|
Full Year Results
|
||||||||||||||||||||||||||||||
2Q22
|
1Q22
|
4Q21
|
3Q21
|
2Q21
|
2022
|
2021
|
2021
|
|||||||||||||||||||||||||
Core earnings available to common shareholders
|
$
|
1,502
|
$
|
1,500
|
$
|
1,637
|
$
|
1,480
|
$
|
1,618
|
$
|
3,002
|
$
|
3,204
|
$
|
6,321
|
||||||||||||||||
Annualized core earnings available to common shareholders
|
$
|
6,022
|
$
|
6,085
|
$
|
6,483
|
$
|
5,874
|
$
|
6,485
|
$
|
6,053
|
$
|
6,460
|
$
|
6,321
|
||||||||||||||||
Average common shareholders’ equity (see below)
|
$
|
49,814
|
$
|
51,407
|
$
|
51,049
|
$
|
49,075
|
$
|
46,757
|
$
|
50,611
|
$
|
46,865
|
$
|
48,463
|
||||||||||||||||
Core ROE (annualized) (%)
|
12.1
|
%
|
11.8
|
%
|
12.7
|
%
|
12.0
|
%
|
13.9
|
%
|
12.0
|
%
|
13.8
|
%
|
13.0
|
%
|
||||||||||||||||
Average common shareholders’ equity
|
||||||||||||||||||||||||||||||||
Total shareholders' and other equity
|
$
|
55,500
|
$
|
56,457
|
$
|
58,408
|
$
|
55,457
|
$
|
53,466
|
$
|
55,500
|
$
|
53,466
|
$
|
58,408
|
||||||||||||||||
Less: Preferred shares and other equity
|
(6,660
|
)
|
(5,670
|
)
|
(6,381
|
)
|
(5,387
|
)
|
(5,387
|
)
|
(6,660
|
)
|
(5,387
|
)
|
(6,381
|
)
|
||||||||||||||||
Common shareholders' equity
|
$
|
48,840
|
$
|
50,787
|
$
|
52,027
|
$
|
50,070
|
$
|
48,079
|
$
|
48,840
|
$
|
48,079
|
$
|
52,027
|
||||||||||||||||
Average common shareholders’ equity
|
$
|
49,814
|
$
|
51,407
|
$
|
51,049
|
$
|
49,075
|
$
|
46,757
|
$
|
50,611
|
$
|
46,865
|
$
|
48,463
|
Quarterly Results
|
YTD Results
|
Full Year Results
|
||||||||||||||||||||||||||||||
2Q22
|
1Q22
|
4Q21
|
3Q21
|
2Q21
|
2022
|
2021
|
2021
|
|||||||||||||||||||||||||
Core EPS
|
||||||||||||||||||||||||||||||||
Core earnings available to common shareholders
|
$
|
1,502
|
$
|
1,500
|
$
|
1,637
|
$
|
1,480
|
$
|
1,618
|
$
|
3,002
|
$
|
3,204
|
$
|
6,321
|
||||||||||||||||
Diluted weighted average common shares outstanding (millions)
|
1,924
|
1,942
|
1,946
|
1,946
|
1,946
|
1,933
|
1,946
|
1,946
|
||||||||||||||||||||||||
Core earnings per share
|
$
|
0.78
|
$
|
0.77
|
$
|
0.84
|
$
|
0.76
|
$
|
0.83
|
$
|
1.55
|
$
|
1.65
|
$
|
3.25
|
||||||||||||||||
Core EPS, CER basis
|
||||||||||||||||||||||||||||||||
Core earnings available to common shareholders, CER basis
|
$
|
1,502
|
$
|
1,495
|
$
|
1,639
|
$
|
1,475
|
$
|
1,648
|
$
|
2,997
|
$
|
3,220
|
$
|
6,334
|
||||||||||||||||
Diluted weighted average common shares outstanding (millions)
|
1,924
|
1,942
|
1,946
|
1,946
|
1,946
|
1,933
|
1,946
|
1,946
|
||||||||||||||||||||||||
Core earnings per share, CER basis
|
$
|
0.78
|
$
|
0.77
|
$
|
0.84
|
$
|
0.76
|
$
|
0.85
|
$
|
1.55
|
$
|
1.65
|
$
|
3.25
|
As at
|
June 30, 2022
|
March 31, 2022
|
Dec 31, 2021
|
Sept 30, 2021
|
June 30, 2021
|
|||||||||||||||
Total invested assets
|
$
|
402,329
|
$
|
409,401
|
$
|
427,098
|
$
|
419,087
|
$
|
405,209
|
||||||||||
Less: Non Global WAM total invested assets
|
398,362
|
405,933
|
422,640
|
414,754
|
400,998
|
|||||||||||||||
Total Invested Assets – Global WAM
|
3,967
|
3,468
|
4,458
|
4,333
|
4,211
|
|||||||||||||||
Total segregated funds net assets
|
$
|
334,903
|
$
|
371,928
|
$
|
399,788
|
$
|
387,799
|
$
|
383,845
|
||||||||||
Less: Non Global WAM total segregated funds net assets
|
121,624
|
135,314
|
147,221
|
143,248
|
141,227
|
|||||||||||||||
Total Segregated funds net assets – Global WAM
|
213,279
|
236,614
|
252,567
|
244,551
|
242,618
|
|||||||||||||||
Global WAM total invested assets and segregated funds net assets
|
$
|
217,246
|
$
|
240,082
|
$
|
257,025
|
$
|
248,884
|
$
|
246,829
|
||||||||||
Global WAM AUMA
|
||||||||||||||||||||
Total Invested Assets
|
$
|
3,967
|
$
|
3,468
|
$
|
4,458
|
$
|
4,333
|
$
|
4,211
|
||||||||||
Segregated funds net assets
|
||||||||||||||||||||
Segregated funds net assets - Institutional
|
4,098
|
4,338
|
4,470
|
4,400
|
4,229
|
|||||||||||||||
Segregated funds net assets - Other
|
209,181
|
232,276
|
248,097
|
240,151
|
238,389
|
|||||||||||||||
Total
|
213,279
|
236,614
|
252,567
|
244,551
|
242,618
|
|||||||||||||||
Mutual funds
|
250,445
|
274,665
|
290,863
|
277,421
|
265,110
|
|||||||||||||||
Institutional asset management(1)
|
100,205
|
101,105
|
106,407
|
103,732
|
99,983
|
|||||||||||||||
Other funds
|
12,110
|
13,269
|
14,001
|
12,562
|
12,232
|
|||||||||||||||
Total Global WAM AUM
|
580,006
|
629,121
|
668,296
|
642,599
|
624,154
|
|||||||||||||||
Assets under administration
|
164,697
|
178,843
|
187,631
|
181,013
|
174,376
|
|||||||||||||||
Total Global WAM AUMA
|
$
|
744,703
|
$
|
807,964
|
$
|
855,927
|
$
|
823,612
|
$
|
798,530
|
||||||||||
Total Global WAM AUMA
|
$
|
744,703
|
$
|
807,964
|
$
|
855,927
|
$
|
823,612
|
$
|
798,530
|
||||||||||
CER adjustment(2)
|
-
|
15,962
|
6,878
|
3,490
|
19,372
|
|||||||||||||||
Total Global WAM AUMA, CER basis
|
$
|
744,703
|
$
|
823,926
|
$
|
862,805
|
$
|
827,102
|
$
|
817,902
|
(1) |
Institutional asset management excludes Institutional segregated funds net assets.
|
(2) |
The impact of updating foreign exchange rates to that which was used in 2Q22.
|
Quarterly Results
|
YTD Results
|
Full Year Results
|
||||||||||||||||||||||||||||||
2Q22
|
1Q22
|
4Q21
|
3Q21
|
2Q21
|
2022
|
2021
|
2021
|
|||||||||||||||||||||||||
Expense Efficiency Ratio
|
||||||||||||||||||||||||||||||||
Core general expenses
|
$
|
1,843
|
$
|
1,877
|
$
|
1,973
|
$
|
1,904
|
$
|
1,794
|
$
|
3,720
|
$
|
3,676
|
$
|
7,553
|
||||||||||||||||
Core earnings (pre-tax)
|
1,900
|
1,876
|
2,054
|
1,811
|
2,036
|
3,776
|
4,031
|
7,896
|
||||||||||||||||||||||||
Total - Core earnings (pre-tax) and Core general expenses
|
$
|
3,743
|
$
|
3,753
|
$
|
4,027
|
$
|
3,715
|
$
|
3,830
|
$
|
7,496
|
$
|
7,707
|
$
|
15,449
|
||||||||||||||||
Expense Efficiency Ratio
|
49.2
|
%
|
50.0
|
%
|
49.0
|
%
|
51.3
|
%
|
46.8
|
%
|
49.6
|
%
|
47.7
|
%
|
48.9
|
%
|
||||||||||||||||
Core general expenses
|
||||||||||||||||||||||||||||||||
General expenses - Financial Statements
|
$
|
1,843
|
$
|
1,898
|
$
|
2,000
|
$
|
1,904
|
$
|
1,892
|
$
|
3,741
|
$
|
3,924
|
$
|
7,828
|
||||||||||||||||
Less: General expenses included in items excluded from core earnings
|
||||||||||||||||||||||||||||||||
Restructuring charge
|
-
|
-
|
-
|
-
|
-
|
-
|
150
|
150
|
||||||||||||||||||||||||
Integration and acquisition
|
-
|
8
|
-
|
-
|
-
|
8
|
-
|
-
|
||||||||||||||||||||||||
Legal provisions and Other expenses
|
-
|
13
|
27
|
-
|
98
|
13
|
98
|
125
|
||||||||||||||||||||||||
Total
|
$
|
-
|
$
|
21
|
$
|
27
|
$
|
-
|
$
|
98
|
$
|
21
|
$
|
248
|
$
|
275
|
||||||||||||||||
Core general expenses
|
$
|
1,843
|
$
|
1,877
|
$
|
1,973
|
$
|
1,904
|
$
|
1,794
|
$
|
3,720
|
$
|
3,676
|
$
|
7,553
|
||||||||||||||||
Core general expenses
|
$
|
1,843
|
$
|
1,877
|
$
|
1,973
|
$
|
1,904
|
$
|
1,794
|
$
|
3,720
|
$
|
3,676
|
$
|
7,553
|
||||||||||||||||
CER adjustment(1)
|
-
|
(11
|
)
|
(7
|
)
|
(11
|
)
|
17
|
(11
|
)
|
(9
|
)
|
(26
|
)
|
||||||||||||||||||
Core general expenses, CER basis
|
$
|
1,843
|
$
|
1,866
|
$
|
1,966
|
$
|
1,893
|
$
|
1,811
|
$
|
3,709
|
$
|
3,667
|
$
|
7,527
|
(1) |
The impact of updating foreign exchange rates to that which was used in 2Q22.
|